[(1S,2S,3R,4S,5R,6S)-2,3-diacetyloxy-6-hydroxy-5-[(Z)-2-methylbut-2-enoyl]oxy-4-(2-methylbut-2-enoyloxy)cyclohexyl] 2-methylbut-2-enoate

Details

Top
Internal ID 1b4ea773-1885-4282-89c9-6b773226250f
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Pentacarboxylic acids and derivatives
IUPAC Name [(1S,2S,3R,4S,5R,6S)-2,3-diacetyloxy-6-hydroxy-5-[(Z)-2-methylbut-2-enoyl]oxy-4-(2-methylbut-2-enoyloxy)cyclohexyl] 2-methylbut-2-enoate
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C25H34O11/c1-9-12(4)23(29)34-18-17(28)19(35-24(30)13(5)10-2)21(36-25(31)14(6)11-3)22(33-16(8)27)20(18)32-15(7)26/h9-11,17-22,28H,1-8H3/b12-9?,13-10-,14-11?/t17-,18-,19+,20-,21-,22+/m0/s1
InChI Key DSYJAAFDCLPHRE-NAZUJLCQSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C25H34O11
Molecular Weight 510.50 g/mol
Exact Mass 510.21011190 g/mol
Topological Polar Surface Area (TPSA) 152.00 Ų
XlogP 2.80
Atomic LogP (AlogP) 1.86
H-Bond Acceptor 11
H-Bond Donor 1
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(1S,2S,3R,4S,5R,6S)-2,3-diacetyloxy-6-hydroxy-5-[(Z)-2-methylbut-2-enoyl]oxy-4-(2-methylbut-2-enoyloxy)cyclohexyl] 2-methylbut-2-enoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9719 97.19%
Caco-2 - 0.6303 63.03%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Mitochondria 0.8559 85.59%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9227 92.27%
OATP1B3 inhibitior + 0.9553 95.53%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior + 0.7388 73.88%
P-glycoprotein inhibitior + 0.7970 79.70%
P-glycoprotein substrate - 0.9768 97.68%
CYP3A4 substrate - 0.5476 54.76%
CYP2C9 substrate - 0.5954 59.54%
CYP2D6 substrate - 0.8999 89.99%
CYP3A4 inhibition - 0.9193 91.93%
CYP2C9 inhibition - 0.9537 95.37%
CYP2C19 inhibition - 0.8843 88.43%
CYP2D6 inhibition - 0.9010 90.10%
CYP1A2 inhibition - 0.9491 94.91%
CYP2C8 inhibition - 0.9815 98.15%
CYP inhibitory promiscuity - 0.9278 92.78%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.6963 69.63%
Carcinogenicity (trinary) Non-required 0.5733 57.33%
Eye corrosion - 0.9020 90.20%
Eye irritation - 0.7808 78.08%
Skin irritation - 0.5576 55.76%
Skin corrosion - 0.9689 96.89%
Ames mutagenesis - 0.6737 67.37%
Human Ether-a-go-go-Related Gene inhibition - 0.3816 38.16%
Micronuclear + 0.6100 61.00%
Hepatotoxicity - 0.5125 51.25%
skin sensitisation - 0.5852 58.52%
Respiratory toxicity - 0.8444 84.44%
Reproductive toxicity + 0.5556 55.56%
Mitochondrial toxicity - 0.7750 77.50%
Nephrotoxicity + 0.7087 70.87%
Acute Oral Toxicity (c) IV 0.3981 39.81%
Estrogen receptor binding + 0.6320 63.20%
Androgen receptor binding - 0.7278 72.78%
Thyroid receptor binding + 0.5418 54.18%
Glucocorticoid receptor binding - 0.5194 51.94%
Aromatase binding - 0.7031 70.31%
PPAR gamma + 0.5621 56.21%
Honey bee toxicity - 0.6639 66.39%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity - 0.7655 76.55%
Fish aquatic toxicity + 0.9497 94.97%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.94% 96.09%
CHEMBL2581 P07339 Cathepsin D 82.32% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 82.29% 91.11%
CHEMBL340 P08684 Cytochrome P450 3A4 81.65% 91.19%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Inula cappa

Cross-Links

Top
PubChem 162822551
LOTUS LTS0148064
wikiData Q104988114